Literature DB >> 8942882

Endophthalmitis associated with microbial keratitis.

I U Scott1, H W Flynn, W Feuer, S C Pflugfelder, E C Alfonso, R K Forster, D Miller.   

Abstract

PURPOSE: The purpose of the study is to investigate possible risk factors, organisms cultured, and visual acuity outcomes of endophthalmitis associated with microbial keratitis.
METHODS: Records were reviewed of all patients with both positive corneal and positive intraocular cultures at the Bascom Palmer Eye Institute between January 1, 1990, and March 31, 1995.
RESULTS: Thirteen (92.9%) of 14 patients identified had documented keratitis before the diagnosis of endophthalmitis was made. Thirteen (92.9%) patients recently had used 1% prednisolone acetate eye drops, 2 (14.3%) received oral prednisone, and 5 (35.7%) were being treated for systemic conditions associated with relative immune dysfunction. Eight (57.1%) patients had a history of ocular surgery, and seven (50.0%) had wound abnormalities. Eight (57.1%) patients lacked an intact posterior capsule, four (28.6%) had a corneal perforation, and three (21.4%) had a history of dry eye. Gram-negative organisms (7), Staphylococcus aureus (3), streptococcal species (2), and fungi (4) were the most frequently isolated organisms. Coagulase-negative staphylococci were not isolated. Six (42.9%) patients achieved a post-treatment visual acuity of 20/200 or better. Three (21.4%) patients underwent enucleation or evisceration. Although not statistically significant, there was an association between appropriate initial antibiotic therapy and improved visual outcomes.
CONCLUSION: Patients in whom endophthalmitis associated with microbial keratitis develops have a frequent history of corticosteroid use, systemic conditions associated with relative immune dysfunction, lack of an intact posterior capsule, dry eye, wound abnormalities, and/or corneal perforation. In general, agents cultured consisted of organisms less frequently reported to be the causative agents in series of postoperative and post-traumatic endophthalmitis. Post-treatment visual outcomes generally were poor.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8942882     DOI: 10.1016/s0161-6420(96)30415-6

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  25 in total

Review 1.  Locally administered ocular corticosteroids: benefits and risks.

Authors:  Charles N J McGhee; Simon Dean; Helen Danesh-Meyer
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

2.  Pharmacokinetics of intravenously administered tigecycline in eye compartments: an experimental study.

Authors:  Muammer Ozcimen; Yasar Sakarya; Serap Ozcimen; Sertan Goktas; Rabia Sakarya; Ismail Alpfidan; Erkan Erdogan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-08-23       Impact factor: 3.117

3.  Bacillus cereus-induced permeability of the blood-ocular barrier during experimental endophthalmitis.

Authors:  Andrea L Moyer; Raniyah T Ramadan; Billy D Novosad; Roger Astley; Michelle C Callegan
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-03-05       Impact factor: 4.799

4.  Comment on "Surgical management of fungal endophthalmitis resulting from fungal keratitis".

Authors:  Dubbaka Srujana; Reena Singh; Koushik Tripathy
Journal:  Int J Ophthalmol       Date:  2017-09-18       Impact factor: 1.779

Review 5.  Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions.

Authors:  Michelle C Callegan; Michael Engelbert; David W Parke; Bradley D Jett; Michael S Gilmore
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

6.  Aspergillus flavus endophthalmitis after penetrating keratoplasty combined with cataract phacoemulsification and IOL implantation.

Authors:  Leopoldo Spadea; Alessandro Abbouda; Irene Abicca; Maria Pia Paroli
Journal:  Int Ophthalmol       Date:  2014-12-09       Impact factor: 2.031

7.  Changing trends in the clinical course and outcome of bacterial keratitis at King Khaled Eye Specialist Hospital.

Authors:  Ali Al-Shehri; Sabah Jastaneiah; Michael D Wagoner
Journal:  Int Ophthalmol       Date:  2008-04-03       Impact factor: 2.031

8.  Risk factors, microbial profiles and prognosis of microbial keratitis-associated endophthalmitis in high-risk eyes.

Authors:  Evelyn C O'Neill; Jonathan Yeoh; David C A Fabinyi; Dermot Cassidy; Rasik B Vajpayee; Penelope Allen; Paul P Connell
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-17       Impact factor: 3.117

9.  Endophthalmitis: A review of recent trends.

Authors:  Janice R Safneck
Journal:  Saudi J Ophthalmol       Date:  2012-03-03

Review 10.  Ocular Infection: Endophthalmitis.

Authors:  Stephen G Schwartz; Harry W Flynn; Taraprasad Das; William F Mieler
Journal:  Dev Ophthalmol       Date:  2015-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.